Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders
CA 2190180 C · Owner: Synthetic Blood International, Inc. · Inventors: Clark, Leland C. Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of assisting a mammal having a lung disorder to breathe ambient gas normally, i.e. without the assistance of a ventilator. The method includes providing an animal having a lung disorder such as surfactant deficiency, stiff lung or hyperinflated lung syndrome, and instilling a minimum effective dose of a perfluorochemical liquid or emulsion through the trachea for coating the alveolar sacs of a lung of the mammal. The preferred perfluorochemicals have a very low vapor pressure to avoid inducing hyperinflated lung syndrome and are supplied in a minimum effective dosage sufficient to coat the inner lung surfaces. The perfluorochemicals are permeable to the ambient gas and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 12, 1995 and granted October 3, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 12, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 12, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.